Rem3dy Health Secures Latest Funding Round

Rem3dy Health secured an undisclosed amount in its latest funding round, adding another data point to the Healthcare & Life Sciences funding market.

Rem3dy Health Raises an undisclosed amount in Funding

Rem3dy Health closes £14m round at £84m valuation to fund international growth. The deal aims to fund international growth.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Rem3dy Health operates in Healthcare & Life Sciences. Rem3dy Health's funding round shows investors are still backing digital health platforms with real scale narratives. At fresh capital, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Rem3dy Health operates as a Digital Health company. The transaction supports efforts to fund international growth.

Looking Ahead

Rem3dy Health closes £14m round at £84m valuation to fund international growth

Source reference: original announcement/article.